850482C

16:0-18:0 (11-12BR) PC

1-palmitoyl-2-(11,12-dibromo)stearoyl-sn-glycero-3-phosphocholine, chloroform

• Synonym(e): 1-hexadecanoyl-2-(11,12-dibromooctadecanoyl)-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₄₂H₈₂NO₈PBr₂
• CAS-Nummer: 324054-54-8
• Molekulargewicht: 919.88
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (850482C-10mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 850482C
• Konzentration: 10 mg/mL (850482C-10mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

16:0-18:0 (11-12BR) PC (1-palmitoyl-2-(11,12-dibromo) stearoyl-sn-glycero-3-phosphocholine) consists of brominated stearoyl chains. This brominated-PC lipid is non-hygroscopic and has a stability of 1 year.

Anwendung

16:0-18:0 (11-12BR) PC (1-palmitoyl-2-(11,12-dibromo) stearoyl-sn-glycero-3-phosphocholine) may be used:

• in phospholipid vesicle preparation for tryptophan (Trp) penetration depth experiments
• to determine the bromination effect at different positions along the fatty acid chains
• for quenching of human heat shock protein 70 (Hsp70) tryptophan (Trp) fluorescence

Biochem./physiol. Wirkung

16:0-18:0 (11-12BR) PC (1-palmitoyl-2-(11,12-dibromo) stearoyl-sn-glycero-3-phosphocholine) can be used in the preparation of vesicles.

Verpackung

5 mL Clear Glass Sealed Ampule (850482C-10mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3